After "strong oil and gas shows" reported last week as the Kelin 94-1 well approached target depth, a price supportive exploration update is expected in the next few days.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%